Veronesi Francesca, Zielli Simone Ottavio, Brogini Silvia, Artioli Elena, Arceri Alberto, Mazzotti Antonio, Faldini Cesare, Giavaresi Gianluca
Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Via Di Barbiano 1/10, 40136 Bologna, Italy.
1st Orthopaedic and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, Via Putti 1, 40136 Bologna, Italy.
Bioengineering (Basel). 2024 Sep 27;11(10):970. doi: 10.3390/bioengineering11100970.
Scaffolds are widely used devices for the treatment of osteochondral lesions of the talus (OCLT), aimed at enhancing mechanical stability and fostering chondrogenic differentiation. A systematic review and meta-analysis were performed to evaluate the safety, and clinical and radiological results of scaffolds for OCLT management. On 2 January 2024, a search was performed in four databases (PubMed, Embase, Web of Science, and Scopus), according to PRISMA guidelines. The risk of bias in the included studies was also evaluated. Thirty clinical studies were included in the qualitative analysis: 12 retrospective case series, 3 retrospective comparative studies, 9 prospective case series, 1 prospective comparative study, and 1 Randomized Controlled Trial (RCT). Natural scaffolds, such as bilayer collagen (COLL)I/III and hyaluronic scaffolds, were the most employed. Only minor adverse events were observed, even if more serious complications were shown, especially after medial malleolar osteotomy. An overall clinical and radiological improvement was observed after a mean of 36.3 months of follow-up. Patient age and Body Mass Index (BMI), lesion size, and location were correlated with the clinical outcomes, while meta-analysis revealed significant improvement in clinical scores with hyaluronic scaffolds compared to microfracture alone. This study highlights the safety and positive clinical outcomes associated with the use of scaffolds for OCLT. In the few available comparative studies, scaffolds have also demonstrated superior clinical outcomes compared to microfractures alone. Nevertheless, the analysis has shown the limitations of the current literature, characterized by an overall low quality and scarcity of RCTs.
支架是广泛用于治疗距骨骨软骨损伤(OCLT)的装置,旨在增强机械稳定性并促进软骨形成分化。进行了一项系统综述和荟萃分析,以评估用于OCLT治疗的支架的安全性、临床和放射学结果。根据PRISMA指南,于2024年1月2日在四个数据库(PubMed、Embase、Web of Science和Scopus)中进行了检索。还评估了纳入研究的偏倚风险。定性分析纳入了30项临床研究:12项回顾性病例系列、3项回顾性比较研究、9项前瞻性病例系列、1项前瞻性比较研究和1项随机对照试验(RCT)。最常用的是天然支架,如双层胶原(COLL)I/III和透明质酸支架。即使出现了更严重的并发症,尤其是在内侧踝截骨术后,也仅观察到轻微不良事件。平均随访36.3个月后,观察到总体临床和放射学改善。患者年龄和体重指数(BMI)、病变大小和位置与临床结果相关,而荟萃分析显示,与单纯微骨折相比,透明质酸支架的临床评分有显著改善。本研究强调了使用支架治疗OCLT的安全性和积极的临床结果。在少数可用的比较研究中,与单纯微骨折相比,支架也显示出更好的临床结果。然而,分析表明了当前文献的局限性,其特点是总体质量较低且RCT稀缺。